Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8625 |
High Similarity |
NPD7075 |
Discontinued |
0.8608 |
High Similarity |
NPD6801 |
Discontinued |
0.85 |
High Similarity |
NPD3817 |
Phase 2 |
0.8481 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8438 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8366 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8323 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8291 |
Intermediate Similarity |
NPD5403 |
Approved |
0.825 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8229 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8165 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8165 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8165 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8165 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8165 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8155 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8103 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8095 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8037 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7975 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7953 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7953 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7935 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7919 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7907 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7892 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7866 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7857 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7826 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7799 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7759 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD919 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7688 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7677 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7674 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7637 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7637 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7636 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7633 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7611 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7558 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7554 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7542 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7539 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7539 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7528 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD37 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7452 |
Intermediate Similarity |
NPD943 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7414 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD920 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7396 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7344 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7273 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7248 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7231 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7222 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7191 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7188 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7184 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.716 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7112 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7104 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7088 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7073 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7073 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7033 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7033 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7032 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7026 |
Intermediate Similarity |
NPD7584 |
Approved |
0.702 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7 |
Intermediate Similarity |
NPD411 |
Approved |
0.6993 |
Remote Similarity |
NPD9268 |
Approved |
0.6983 |
Remote Similarity |
NPD2403 |
Approved |
0.6979 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6966 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD2798 |
Approved |
0.6952 |
Remote Similarity |
NPD8435 |
Approved |
0.6952 |
Remote Similarity |
NPD8361 |
Approved |
0.6952
|
Remote Similarity |
NPD8360 |
Approved |